CRISPR Therapeutics (NASDAQ: CRSP)
CRISPR Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CRISPR Therapeutics Company Info
CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases.
News & Analysis
Top Biotech ETFs to Buy Now
Here are the five best biotech ETFs to invest in right now.
Investing in Gene-Editing Stocks
Could This Beaten-Down Stock Help You Become a Millionaire?
The company would need to maintain the strong momentum it's had this year for a long time.
Who Is Cathie Wood?
How to Invest in CRISPR Therapeutics Stock
Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190%
These companies are reaching key milestones.
The Best CRISPR Companies to Invest In
These CRISPR stocks could be big winners for patient investors.
1 Reason Every Investor Should Know About CRISPR Therapeutics (CRSP)
This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading the developmental race).
Valuation
Podcast Episodes
"The Era of the Gene-Edited Human Is Here"
An investor's look.
Breaking Down CRISPR Technology
What investors need to know.
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Did China’s “Designer Babies” Just Open Pandora’s Box?
What will this mean for healthcare and for the future of society?
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.